Skip to Main Content

CRISPR, Dodo Birds, Woolly Mammoths, & Gene Editing

Cambridge Associates

According to scientists, 30,000 species per year are being driven towards extinction and 50% of all species could be extinct by 2050 because of climate change. But what if there was something we could do, in addition to conservation, to change this trajectory?

That’s what the scientists and engineers at Colossal Biosciences are working towards: reversing extinction. Using CRISPR and advanced gene editing techniques, they plan to bring back the woolly mammoth and the dodo bird to help reverse the impacts of climate change and complement existing conservation efforts.

Join us for this podcast episode of Unseen Upside: Investments Beyond Their Returns, where we discuss this topic with Ben Lamm (Colossal Biosciences); Tom Chi (At One Ventures); and John Calvelli (Wildlife Conservation Society).

Listen now to uncover the Unseen Upside.

Read the transcript

Please note that as of August 29, 2023, Stitcher has been discontinued.

Explore more episodes

Listen now


Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company. Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.

Enjoying the podcast? Subscribe, rate, and review Unseen Upside: Investments Beyond Their Returns on Apple Podcasts and Spotify.

Have an idea for an episode or interested in being a guest? Email to get involved.